Annual Drug Patent Expirations for TYBOST
Tybost is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for TYBOST.
This drug has two hundred and forty-four patent family members in thirty-nine countries.
The generic ingredient in TYBOST is cobicistat. One supplier is listed for this compound. Additional details are available on the cobicistat profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
